Transfer of chromosome 8 into two breast cancer cell lines: Total exclusion of three regions indicates location of putative in vitro growth suppressor genes

Cancer Genetics and Cytogenetics

Volumn 143, Issue 2, 2003, Pages 100-112

  Wilson, Peter ^a   Cuthbert, Andrew ^b   Marsh, Anna ^a   Arnold, Jeremy ^a   Flanagan, James ^a   Mulford, Christine ^a   Trott, Deborah ^b   Baker, Elizabeth ^b   Purdie, David ^a   Newbold, Robert ^b   Chenevix Trench, Georgia ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR;

ADULT; ALLELE; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL GROWTH; CHROMOSOME 8; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; FEMALE; GENE LOCATION; GENETIC ANALYSIS; GENOTYPE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYBRID CELL; IN VITRO STUDY; MICROSATELLITE MARKER; MOLECULAR CLONING; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0038054378     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00850-6     Document Type: Article

References (69)

1. Wright K., Wilson P.J., Kerr J., Do K., Hurst T., Khoo S.K., Ward B., Chenevix-Trench G. Frequent loss of heterozygosity and three critical regions on the short arm of chromosome 8 in ovarian adenocarcinomas. Oncogene. 17:1998;1185-1188.
2. Prasad M.A., Trybus T.M., Wojno K.J., Macoska J.A. Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers. identification of a potential tumor suppressor gene site Genes Chromosomes Cancer. 23:1998;255-262.
3. Pineau P., Nagai H., Prigent S., Wei Y., Gyapay G., Weissenbach J., Tiollais P., Buendia M.A., Dejean A. Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma. Oncogene. 18:1999;3127-3134.
4. Takle L.A., Knowles M.A. Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer. Oncogene. 12:1996;1083-1087.
5. Wistuba I.I., Behrens C., Virmani A.K., Milchgrub S., Syed S., Lam S., Mackay B., Minna J.D., Gazdar A.F. Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res. 59:1999;1973-1979.
6. Baffa R., Santoro R., Bullrich F., Mandes B., Ishii H., Croce C.M. Definition and refinement of chromosome 8p regions of loss of heterozygosity in gastric cancer. Clin Cancer Res. 6:2000;1372-1377.
7. Bova G.S., MacGrogan D., Levy A., Pin S.S., Bookstein R., Isaacs W.B. Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer. Genomics. 35:1996;46-54.
8. Kagan J., Stein J., Babaian R.J., Joe Y.S., Pisters L.L., Glassman A.B., v on Eschenbach A.C., Troncoso P. Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes. Oncogene. 11:1995;2121-2126.
9. Ishwad C.S., Shuster M., Bockmuhl U., Thakker N., Shah P., Toomes C., Dixon M., Ferrell R.E., Gollin S.M. Frequent allelic loss and homozygous deletion in chromosome band 8p23 in oral cancer. Int J Cancer. 80:1999;25-31.
10. Levy A., Dang U.C., Bookstein R. High-density screen of human tumor cell lines for homozygous deletions of loci on chromosome arm 8p. Genes Chromosomes Cancer. 24:1999;42-47.
11. Van Alewijk D.C., Van der Weiden M.M., Eussen B.J., Van Den Andel-Thijssen L.D., Ehren-van Eekelen C.C., Konig J.J., van Steenbrugge G.J., Dinjens W.N., Trapman J. Identification of a homozygous deletion at 8p12-21 in a human prostate cancer xenograft. Genes Chromosomes Cancer. 24:1999;119-126.
12. Sun P.C., Schmidt A.P., Pashia M.E., Sunwoo J.B., Scholnick S.B. Homozygous deletions define a region of 8p23.2 containing a putative tumor suppressor gene. Genomics. 62:1999;184-188.
13. Zenklusen J.C., Conti C.J., Green E.D. Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31. Nat Genet. 27:2001;392-398.
14. Negrini M., Sabbioni S., Possati L., Rattan S., Corallini A., Barbanti-Brodano G., Croce C.M. Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer. studies on chromosomes 6 and 11 Cancer Res. 54:1994;1331-1336.
15. Phillips K.K., Welch D.R., Miele M.E., Lee J.H., Wei L.L., Weissman B.E. Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11. Cancer Res. 56:1996;1222-1227.
16. Reddy D.E., Sandhu A.K., DeRiel J.K., Athwal R.S., Kaur G.P. Identification of a gene at 16q24.3 that restores cellular senescence in immortal mammary tumor cells. Oncogene. 18:1999;5100-5117.
17. Theile M., Hartmann S., Scherthan H., Arnold W., Deppert W., Frege R., Glaab F., Haensch W., Scherneck S. Suppression of tumorigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes. Oncogene. 10:1995;439-447.
18. Plummer S.J., Adams L., Simmons J.A., Casey G. Localization of a growth suppressor activity in MCF7 breast cancer cells to chromosome 17q24-q25. Oncogene. 14:1997;2339-2345.
19. Casey G., Plummer S., Hoeltge G., Scanlon D., Fasching C., Stanbridge E.J. Functional evidence for a breast cancer growth suppressor gene on chromosome 17. Hum Mol Genet. 2:1993;1921-1927.
20. Cuthbert A.P., Bond J., Trott D.A., Gill S., Broni J., Marriott A., Khoudoli G., Parkinson E.K., Cooper C.S., Newbold R.F. Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. J Natl Cancer Inst. 91:1999;37-45.
21. Yang Y., Kost-Alimova M., Ingvarsson S., Qianhui Q., Kiss H., Szeles A., Kholodnyuk I., Cuthbert A., Klein G., Imreh S. Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice. Proc Natl Acad Sci U S A. 98:2001;1136-1141.
22. Kholodnyuk I., Kost-Alimova M., Kashuba V., Gizatulin R., Szeles A., Stanbridge E.J., Zabarovsky E.R., Klein G., Imreh S. A 3p21.3 region is preferentially eliminated from human chromosome 3/mouse microcell hybrids during tumor growth in SCID mice. Genes Chromosomes Cancer. 18:1997;200-211.
23. Robertson G.P., Furnari F.B., Miele M.E., Glendening M.J., Welch D.R., Fountain J.W., Lugo T.G., Huang H.J., Cavenee W.K. In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma. Proc Natl Acad Sci U S A. 95:1998;9418-9423.
24. Dutrillaux B., Gerbault-Seureau M., Zafrani B. Characterization of chromosomal anomalies in human breast cancer. a comparison of 30 paradiploid cases with few chromosome changes Cancer Genet Cytogenet. 49:1990;203-217.
25. Nishizaki T., DeVries S., Chew K., Goodson W.H. 3rd, Ljung B.M., Thor A., Waldman F.M. Genetic alterations in primary breast cancers and their metastases. direct comparison using modified comparative genomic hybridization Genes Chromosomes Cancer. 19:1997;267-272.
26. Hermsen M.A., Baak J.P., Meijer G.A., Weiss J.M., Walboomers J.W., Snijders P.J., van Diest P.J. Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors. J Pathol. 186:1998;356-362.
27. Larramendy M.L., Lushnikova T., Bjorkqvist A., Wistuba I.I., Virmani A.K., Shivapurkar N., Gazdar A.F., Knuutila S. Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines. Cancer Genet Cytogenet. 119:2000;132-138.
28. Loveday R.L., Greenman J., Simcox D.L., Speirs V., Drew P.J., Monson J.R., Kerin M.J. Genetic changes in breast cancer detected by comparative genomic hybridisation. Int J Cancer. 86:2000;494-500.
29. Lindblom A., Skoog L., Rotstein S., Werelius B., Larsson C., Nordenskjold M. Loss of heterozygosity in familial breast carcinomas. Cancer Res. 53:1993;4356-4361.
30. Radford D.M., Phillips N.J., Fair K.L., Ritter J.H., Holt M., Donis-Keller H. Allelic loss and the progression of breast cancer. Cancer Res. 55:1995;5180-5183. [Erratum: Cancer Res 1996;56:935.].
31. Driouch K., Briffod M., Bieche I., Champeme M.H., Lidereau R. Location of several putative genes possibly involved in human breast cancer progression. Cancer Res. 58:1998;2081-2086.
32. Shen C.Y., Yu J.C., Lo Y.L., Kuo C.H., Yue C.T., Jou Y.S., Huang C.S., Lung J.C., Wu C.W. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma. an implication for mutator phenotype and breast cancer pathogenesis Cancer Res. 60:2000;3884-3892.
33. Sigbjornsdottir B.I., Ragnarsson G., Agnarsson B.A., Huiping C., Barkardottir R.B., Egilsson V., Ingvarsson S. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer. J Med Genet. 37:2000;342-347.
34. Seitz S., Rohde K., Bender E., Nothnagel A., Pidde H., Ullrich O.M., El-Zehairy A., Haensch W., Jandrig B., Kolble K., Schlag P.M., Scherneck S. Deletion mapping and linkage analysis provide strong indication for the involvement of the human chromosome region 8p12-p22 in breast carcinogenesis. Br J Cancer. 76:1997;983-991.
35. Anbazhagan R., Fujii H., Gabrielson E. Loss of heterozygosity of chromosome 8p in breast cancer progression. Am J Hum Genet. 38:1997;A1271.
36. Anbazhagan R., Fujii H., Gabrielson E. Allelic loss of chromosomal arm 8p in breast cancer progression. Am J Pathol. 152:1998;815-819.
37. Seitz S., Werner S., Fischer J., Nothnagel A., Schlag P.M., Scherneck S. Refined deletion mapping in sporadic breast cancer at chromosomal region 8p12-p21 and association with clinicopathological parameters. Eur J Cancer. 36:2000;1507-1513.
38. Kerangueven F., Essioux L., Dib A., Noguchi T., Allione F., Geneix J., Longy M., Lidereau R., Eisinger F., Pebesque M.-J., Jacquemier J., Bonaiti-Pellie C., Sobol H., Birnbaum D. Loss of heterozygosity and linkage analysis in breast carcinoma. indication for a putative third susceptibility gene on the short arm of chromosome 8 Oncogene. 10:1995;1023-1026.
39. Yaremko M.L., Kutza C., Lyzak J., Mick R., Recant W.M., Westbrook C.A. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer. Genes Chromosomes Cancer. 16:1996;189-195.
40. Wang J.C., Radford D.M., Holt M.S., Helms C., Goate A., Brandt W., Parik M., Phillips N.J., DeSchryver K., Schuh M.E., Fair K.L., Ritter J.H., Marshall P., Donis-Keller H. Sequence-ready contig for the 1.4-cM ductal carcinoma in situ loss of heterozygosity region on chromosome 8p22-p23. Genomics. 60:1999;1-11.
41. Yokota T., Yoshimoto M., Akiyama F., Sakamoto G., Kasumi F., Nakamura Y., Emi M. Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1. Cancer. 85:1999;447-452.
42. Suzuki A., Shao X., Song X.Q., Hanaoka T., Irie S., Kashiwada M., Samara G., Close L.G., Aoki T., Fujimori M., Ishikawa Y., Hatori M., Hosaka M., Sakurada A., Sato M., Ohuchi N., Satomi S., Fukushige S., Horii A., Sato T. Identification of a 5-cM region of common allelic loss on 8p12-p21 in human breast cancer and genomic analysis of the hEXT1L/EXTR1/EXTL3 gene in this locus. Int J Oncol. 15:1999;443-451.
43. Dahiya R., Perinchery G., Deng G., Lee C. Multiple sites of loss of heterozygosity on chromosome 8 in human breast cancer has differential correlation with clinical parameters. Int J Oncol. 12:1998;811-816.
44. O'Connell P., Pekkel V., Fuqua S.A., Osborne C.K., Clark G.M., Allred D.C. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst. 90:1998;697-703.
45. Utada Y., Haga S., Kajiwara T., Kasumi F., Sakamoto G., Nakamura Y., Emi M. Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas. Cancer. 88:2000;1410-1416.
46. Seitz S., Rohde K., Bender E., Nothnagel A., Kolble K., Schlag P.M., Schemeck S. Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22. linkage analysis in German breast cancer families Oncogene. 14:1997;741-743.
47. Rahman N., Teare M.D., Seal S., Renard H., Mangion J., Cour C., Thompson D., Shugart Y., Eccles D., Devilee P., Meijers H., Nathanson K.L., Neuhausen S.L., Weber B., Chang-Claude J., Easton D.F., Goldgar D., Stratton M.R. Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22. Oncogene. 19:2000;4170-4173.
48. Nihei N., Ichikawa T., Kawana Y., Kuramochi H., Kugoh H., Oshimura M., Hayata I. Mapping of metastasis suppressor gene(s) for rat prostate cancer on the short arm of human chromosome 8 by irradiated microcell-mediated chromosome transfer. Genes Chromosomes Cancer. 17:1996;260-268.
49. Tanaka K., Kikuchi-Yanoshita R., Muraoka M., Konishi M., Oshimura M., Miyaki M. Suppression of tumorigenicity and invasiveness of colon carcinoma cells by introduction of normal chromosome 8p12-pter. Oncogene. 12:1996;405-410.
50. Gustafson C.E., Wilson P.J., Lukeis R., Baker E., Woollatt E., Annab L., Hawke L., Barrett J.C., Chenevix-Trench G. Functional evidence for a colorectal cancer tumor suppressor gene at chromosome 8p22-23 by monochromosome transfer. Cancer Res. 56:1996;5238-5245.
51. Band V., Zajchowski D., Stenman G., Morton C.C., Kulesa V., Connolly J., Sager R. A newly established metastatic breast tumor cell line with integrated amplified copies of ERBB2 and double minute chromosomes. Genes Chromosomes Cancer. 1:1989;48-58.
52. Band V., Zajchowski D., Swisshelm K., Trask D., Kulesa V., Cohen C., Connolly J., Sager R. Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res. 50:1990;7351-7357.
53. Cuthbert A.P., Trott D.A., Ekong R.M., Jezzard S., England N.L., Themis M., Todd C.M. Construction and characterization of a highly stable human:rodent monochromosomal hybrid panel for genetic complementation and genome mapping studies. Cytogenet Cell Genet. 71:1995;68-76.
54. Trott D.A., Cuthbert A.P., Todd C.M., Themis M., Newbold R.F. Novel use of a selectable fusion gene as an "in-out" marker for studying genetic loss in mammalian cells. Mol Carcinog. 12:1995;213-224.
55. Hayflick L. Subculturing human diploid fibroblast cultures. Kruse P.F. Tissue culture methods and applications. 1973;220-223 Academic Press, New York.
56. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
57. Yang X., Tahin Q., Hu Y.F., Russo I.H., Balsara B.R., Mihaila D., Slater C., Barrett J.C., Russo J. Functional roles of chromosomes 11 and 17 in the transformation of human breast epithelial cells in vitro. Int J Oncol. 15:1999;629-638.
58. Cook W.D., McCaw B.J. Accommodating haploinsufficient tumor suppressor genes in Knudsen's model. Oncogene. 19:2000;3434-3438.
59. Islam M.Q., Islam K. Lack of tumor suppression but induced loss of copies of indigenous chromosome 10 in vitro following microcell-mediated transfer of a deleted human der(9)t(X;9) chromosome to Syrian hamster BHK-191-5C cells. Cytogenet Cell Genet. 87:1999;11-18.
60. Cheng C.W., Wu P.E., Yu J.C., Huang C.S., Yue C.T., Wu C.W., Shen C.Y. Mechanisms of inactivation of E-cadherin in breast carcinoma. modification of the two-hit hypothesis of tumor suppressor gene Oncogene. 20:2001;3814-3823.
61. Macleod K. Tumor suppressor genes. Curr Opin Genet Dev. 10:2000;81-93.
62. Venkatachalam S., Shi Y.P., Jones S.N., Vogel H., Bradley A., Pinkel D., Donehower L.A. Retention of wild-type p53 in tumors from p53 heterozygous mice. reduction of p53 dosage can promote cancer formation EMBO J. 17:1998;4657-4667.
63. Xu X., Brodie S.G., Yang X., Im Y.H., Parks W.T., Chen L., Zhou Y.X., Weinstein M., Kim S.J., Deng C.X. Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice. Oncogene. 19:2000;1868-1874.
64. Fero M.L., Randel E., Gurley K.E., Roberts J.M., Kemp C.J. The murine gene p27Kip1 is haplo-insufficient for tumor suppression. Nature. 396:1998;177-180.
65. Lai J, Flanagan J, Phillips W, Chenevix-Trench G, Arnold J. Analysis of the candidate 8p21 tumor suppressor gene, BNIP3L, in breast and ovarian cancer. Br J Cancer (in press).
66. Wilson P.J., McGlinn E., Marsh A., Evans T., Arnold J., Wright K., Biden K., Young J., Wainwright B., Wicking C., Chenevix-Trench G. Sequence variants of DLC1 in colorectal and ovarian tumors. Hum Mutat. 15:2000;156-165.
67. Ishii H., Baffa R., Numata S.-I., Murakumo Y., Rattan S., Inoue H., Mori M., Fidanza V., Alder H., Croce C.M. The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is alterered in multiple tissues. Proc Natl Acad Sci U S A. 96:1999;3928-3933.
68. Ishii H., Vecchione A., Murakumo Y., Baldassaree G., Numata S., Trapasso F., Alder H., Baffa R., Croce C.M. FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis. Proc Natl Acad Sci U S A. 98:2001;10374-10379.
69. Brown M.R., Chuaqui R., Vocke C.D., Berchuck A., Middleton L.P., Emmert-Buck M.R., Kohn E.C. Allelic loss on chromosome arm 8p. analysis of sporadic epithelial ovarian tumors Gynecol Oncol. 74:1999;98-102.